| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0192 | 2-ethoxystypandrone | Novel potent natural STAT3 signaling inhibitor from Polygonum cuspidatum, inhibiting cell growth and inducing apoptosis of HCC cells and HCC Cancer stem cells. |
|
| DCC0193 | 2-furoyl-ligrlo-amide | Potent and selective PAR2 receptor agonist |
|
| DCC0194 | 2-hexylthio-β,γ-ch2-atp | Non-hydrolyzable ATP analog, acting as an effective and selective NTPDase2 inhibitor |
|
| DCC0195 | 2-hydroxyethyl-sp600125 | Potent and selective JNK inhibitor; Analogue of SP600125 with improved potency and selectivity |
|
| DCC0196 | 2-iodoestradiol | Potent human sex hormone binding globulin (SHBG) ligand |
|
| DCC0197 | 2-mc-1,4-nhq | Inhibitor of the Cdc42-PBD interaction, blocking the association of Cdc42 with the PBD |
|
| DCC0198 | 2-o-acetylcorosolic Acid | Antiatherosclerotic, antihyperlipidemic, antiinflammatory, antifungal, antiviral and antineoplastic |
|
| DCC0199 | 2-oh-5-f-dppro | Novel inhibitor of thioredoxin reductase (TrxR) |
|
| DCC0200 | 2-oxaadamantane 22 | Novel inhibitor of soluble epoxide hydrolase (sEH), showing good solubility, microsomal stability, and selectivity for sEH |
|
| DCC0201 | 2ppg-fk-acrha | Novel double photocaged cathepsin B activity-based probe for monitoring the light-activation by the blue fluorescence of 7-diethylamino-4-hydroxymethyl-coumarin (DEACM) and simultaneously probe the activity of cathepsin B through the green fluorescence of |
|
| DCC0202 | 2r,4r-apdc | Highly selective and relatively potent group II metabotropic glutamate receptor agonist |
|
| DCC0203 | 3,3',4,4',5,5'-hms | Novel pro-angiogenic agent, potently promoting proliferation, migration, invasion and tube formation of human umbilical vein VECs (HUVECs) in vitro |
|
| DCC0204 | 3,3'-biplumbagin | Novel, active, and less toxic anti-tuberculosis (anti-TB) agent |
|
| DCC0205 | 3',3'-c-di(2'f,2'damp) | Novel STING Agonist |
|
| DCC0206 | 3,4,5-tri-cqa | Inhibitor of Beta_amyloid>amyloid β-mediated cellular toxicity |
|
| DCC0207 | 3,4-dcqame | Natural inhibitor of respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane. |
|
| DCC0208 | 3,4-di-o-acetyl-l-rhamnal | Inhibitor of human tyrosyl-DNA phosphodiesterase 1 (TDP1) |
|
| DCC0209 | 3,5-diiodothyronine | Metabolite of thyroid hormones (thyroxine and triiodo-L-thyronine) |
|
| DCC0210 | 3-aceto-2-hydroxybiphenyl | Useful pharmaceutical building block |
|
| DCC0211 | 3-acetoxylteuvincenone G | Natural potent, selective, and efficacious inhibitor of SHP2, suppressing A549 cell proliferation (IC 50 =10.79±0.14μM), invasion and inducing cell apoptosis through SHP2/ERK1/2 and SHP2/AKT pathways |
|
| DCC0212 | 3-acetyldeoxynivalenol | Natural inducer of DNA damage, cell cycle arrest, apoptosis, and autophagy in macrophages |
|
| DCC0213 | 3ac-sl0101 | SL0101 analog, acting as a specific inhibitor of p90 ribosomal S6 kinase (RSK), being approximately 2-fold more potent at inhibiting MCF-7 cell proliferation compared to SL0101 and preferentially decreased MCF-7 cell growth, as compared to the growth of t |
|
| DCC0214 | 3alpha-androstanediol | Endogenous inhibitory androstane neurosteroid and weak androgen, and a major metabolite of dihydrotestosterone (DHT); Potent positive allosteric modulator of the GABAA receptor |
|
| DCC0215 | 3alpha-o-allyl-allopregnanolone | Neuroprotective and proliferative agent with significantly higher stimulatory effect than that of allopregnanolone |
|
| DCC0216 | 3-aminotyrosine Dihydrochloride | Tyrosine drivative, being a useful probe to study the role of redox active tyrosines in enzymes |
|
| DCC0217 | 3beta-androstanediol | Potent endogenous estrogen |
|
| DCC0218 | 3'-bromorubrolide F | Putative natural allosteric modulator of human Hsp90α conformational dynamics by allosteric ligand interaction at the C-terminal domain site 2 |
|
| DCC0219 | 3-brop | Prodrug of the glycolysis inhibitor 3-bromopyruvate (3-BrPA) which targets hexokinase II (HK2) and GAPDH |
|
| DCC0220 | 3-cl-10-oh-thioevodiamine | The first-in-class triple topoisomerase I/topoisomerase II/tubulin inhibitor |
|
| DCC0221 | 3clpro-in-6d | Novel inhibitor of 3C-like protease (3CLpro) of MERS-CoV and severe acute respiratory syndrome coronavirus (SARS-CoV) |
|
